{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T03:02:01Z","timestamp":1767927721055,"version":"3.49.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Health Commission of Guangxi Zhuang Autonomous Region","award":["Z2011455"],"award-info":[{"award-number":["Z2011455"]}]},{"name":"Health Commission of Guangxi Zhuang Autonomous Region","award":["Z20180761"],"award-info":[{"award-number":["Z20180761"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To investigate predictive factors for irreversible organ damage in systemic sclerosis (SSc) and establish a nomogram model.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective study included patients with SSc who were treated at our hospital between March 2013 and March 2023. Irreversible organ damage included heart failure, respiratory failure, renal failure, and gangrene of the hands and feet. Cox and LASSO regression analyses were performed to determine the predictive factors. Based on the results, a nomogram model was developed. The model was evaluated using the C-indices, calibration plots and DCA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 361 patients with systemic sclerosis were randomly divided into the development (n\u2009=\u2009181) and validation (n\u2009=\u2009180) groups. Multivariate Cox regression analysis showed that age \u226565\u2009years, weight loss, digital ulcers, mRSS \u226516, elevated creatinine, elevated myoglobin, elevated C-reactive protein, renal involvement and cardiac involvement were independent risk factors. Based on the LASSO analysis, a nomogram model of irreversible organ damage was established. The C-indices of the development group at 24, 60 and 96\u2009m were 96.7, 84.5 and 85.7, whereas those of the validation group at 24, 60 and 96\u2009m were 86.6, 79.1 and 78.5, respectively. The results of the DCA showed that the nomogram can be used as a valuable tool to predict irreversible organ damage in patients with SSc.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>We included commonly used clinical indicators. According to the nomogram, the probability of irreversible organ damage can be calculated and high-risk patients can be identified.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae083","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T06:35:40Z","timestamp":1707201340000},"page":"658-666","source":"Crossref","is-referenced-by-count":3,"title":["Preliminary nomogram model for predicting irreversible organ damage of patients with systemic sclerosis"],"prefix":"10.1093","volume":"64","author":[{"given":"Xiaocong","family":"Huo","sequence":"first","affiliation":[{"name":"The People\u2019s Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences , Nanning, Guangxi,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxiang","family":"Huang","sequence":"additional","affiliation":[{"name":"The People\u2019s Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences , Nanning, Guangxi,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanting","family":"Yang","sequence":"additional","affiliation":[{"name":"The People\u2019s Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences , Nanning, Guangxi,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengcheng","family":"Wei","sequence":"additional","affiliation":[{"name":"The People\u2019s Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences , Nanning, Guangxi,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danli","family":"Meng","sequence":"additional","affiliation":[{"name":"The People\u2019s Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences , Nanning, Guangxi,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongjun","family":"Huang","sequence":"additional","affiliation":[{"name":"The People\u2019s Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences , Nanning, Guangxi,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinying","family":"Lin","sequence":"additional","affiliation":[{"name":"The People\u2019s Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences , Nanning, Guangxi,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"key":"2025032905212030200_keae083-B1","first-page":"1624","article-title":"Systemic sclerosis: advances and prospects","volume":"390","author":"The Lancet","year":"2017","journal-title":"Lancet"},{"key":"2025032905212030200_keae083-B2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11926-020-00918-3","article-title":"Current and potential new targets in systemic sclerosis therapy: a new hope","volume":"22","author":"Hinchcliff","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"2025032905212030200_keae083-B3","first-page":"103439","article-title":"Is cyclophosphamide still the gold standard in early severe rapidly progressive systemic sclerosis?","author":"Campochiaro","year":"2023","journal-title":"Autoimmun Rev"},{"key":"2025032905212030200_keae083-B4","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/BOR.0000000000000970","article-title":"Emerging cellular and immunotherapies for systemic sclerosis: from mesenchymal stromal cells to CAR-T cells and vaccine-based approaches","volume":"35","author":"Lescoat","year":"2023","journal-title":"Curr Opin Rheumatol"},{"key":"2025032905212030200_keae083-B5","doi-asserted-by":"crossref","first-page":"104088","DOI":"10.1016\/j.lpm.2021.104088","article-title":"Treatment of systemic sclerosis","volume":"50","author":"Thoreau","year":"2021","journal-title":"Presse Med"},{"key":"2025032905212030200_keae083-B6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/BOR.0b013e32834ff2e8","article-title":"Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers","volume":"24","author":"Barnes","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"2025032905212030200_keae083-B7","doi-asserted-by":"crossref","first-page":"152228","DOI":"10.1016\/j.semarthrit.2023.152228","article-title":"Increased oxidative stress response in circulating blood of systemic sclerosis patients\u2014relation to disease characteristics and inflammatory blood biomarkers","volume":"62","author":"Dziedzic","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"2025032905212030200_keae083-B8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13075-023-03141-4","article-title":"Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study","volume":"25","author":"Hamberg","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"2025032905212030200_keae083-B9","doi-asserted-by":"crossref","first-page":"103097","DOI":"10.1016\/j.jaut.2023.103097","article-title":"Non-classical circulating monocytes expressing high levels of microsomal prostaglandin E2 synthase-1 tag an aberrant IFN-response in systemic sclerosis","volume":"140","author":"Villanueva-Martin","year":"2023","journal-title":"J Autoimmun"},{"key":"2025032905212030200_keae083-B10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s41927-022-00262-2","article-title":"Skin model for improving the reliability of the modified Rodnan skin score for systemic sclerosis","volume":"6","author":"Pongkulkiat","year":"2022","journal-title":"BMC Rheumatol"},{"key":"2025032905212030200_keae083-B11","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/1756-185X.13523","article-title":"Evaluation of Scleroderma Clinical Trials Consortium training recommendations on modified Rodnan skin score assessment in scleroderma","volume":"22","author":"Low","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"2025032905212030200_keae083-B12","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2025032905212030200_keae083-B13","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.amjmed.2005.01.062","article-title":"Frailty, hospitalization, and progression of disability in a cohort of disabled older women","volume":"118","author":"Boyd","year":"2005","journal-title":"Am J Med"},{"key":"2025032905212030200_keae083-B14","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"2025032905212030200_keae083-B15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"key":"2025032905212030200_keae083-B16","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"2025032905212030200_keae083-B17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis. An International Working Group Report","volume":"194","author":"Collard","year":"2016","journal-title":"Am J Resp Crit Care"},{"key":"2025032905212030200_keae083-B18","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.kint.2021.06.028","article-title":"Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: improving Global Outcomes (KDIGO) Consensus Conference","volume":"100","author":"Lameire","year":"2021","journal-title":"Kidney Int"},{"key":"2025032905212030200_keae083-B19","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1080\/14656566.2020.1793960","article-title":"An update on the pharmacotherapeutic options and treatment strategies for systemic sclerosis","volume":"21","author":"McMahan","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"2025032905212030200_keae083-B20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.clnesp.2020.09.030","article-title":"Nutritional status and predictors of weight loss in patients with systemic sclerosis","volume":"40","author":"Hvas","year":"2020","journal-title":"Clin Nutr ESPEN"},{"key":"2025032905212030200_keae083-B21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10067-019-04598-y","article-title":"Malnutrition, associated clinical factors, and depression in systemic sclerosis: a cross-sectional study","volume":"39","author":"Turk","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2025032905212030200_keae083-B22","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00296-017-3753-y","article-title":"Malnutrition is an independent risk factor for mortality in Mexican patients with systemic sclerosis: a cohort study","volume":"37","author":"Cruz-Dominguez","year":"2017","journal-title":"Rheumatol Int"},{"key":"2025032905212030200_keae083-B23","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.3390\/diagnostics11112118","article-title":"Diet in scleroderma: is there a need for intervention?","volume":"11","author":"Burlui","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"2025032905212030200_keae083-B24","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.gtc.2021.08.005","article-title":"Scleroderma and the esophagus","volume":"50","author":"Ahuja","year":"2021","journal-title":"Gastroenterol Clin North Am"},{"key":"2025032905212030200_keae083-B25","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/0148607115597883","article-title":"Medical Nutrition Therapy for Patients With Advanced Systemic Sclerosis (MNT PASS): a pilot intervention study","volume":"41","author":"Doerfler","year":"2017","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"2025032905212030200_keae083-B26","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41584-020-0386-4","article-title":"Raynaud phenomenon and digital ulcers in systemic sclerosis","volume":"16","author":"Hughes","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2025032905212030200_keae083-B27","doi-asserted-by":"crossref","first-page":"104449","DOI":"10.1016\/j.mvr.2022.104449","article-title":"Association between oxygen delivery and digital ulcers in systemic sclerosis","volume":"145","author":"Akdogan","year":"2023","journal-title":"Microvasc Res"},{"key":"2025032905212030200_keae083-B28","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.55730\/1300-0144.5535","article-title":"Causes of severe infections in patients with systemic sclerosis and associated factors","volume":"52","author":"Yayla","year":"2022","journal-title":"Turk J Med Sci"},{"key":"2025032905212030200_keae083-B29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.rdc.2023.01.004","article-title":"Treatment of vascular complications in systemic sclerosis: what is the best approach to diagnosis and management of renal crisis and digital ulcers?","volume":"49","author":"Hughes","year":"2023","journal-title":"Rheum Dis Clin North Am"},{"key":"2025032905212030200_keae083-B30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/2397198318758607","article-title":"Kidney involvement in systemic sclerosis: from pathogenesis to treatment","volume":"3","author":"Bruni","year":"2018","journal-title":"J Scleroderma Relat Disord"},{"key":"2025032905212030200_keae083-B31","first-page":"2423","article-title":"Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study","volume":"34","author":"Hachulla","year":"2007","journal-title":"J Rheumatol"},{"key":"2025032905212030200_keae083-B32","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/thorax-2022-219226","article-title":"Mediators of systemic sclerosis-associated interstitial lung disease (SSc-ILD): systematic review and meta-analyses","volume":"78","author":"Fields","year":"2023","journal-title":"Thorax"},{"key":"2025032905212030200_keae083-B33","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead332","article-title":"Performance of serum biomarkers reflective of different pathogenic processes in systemic sclerosis-associated interstitial lung disease","author":"Gyorfi","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2025032905212030200_keae083-B34","doi-asserted-by":"crossref","first-page":"106689","DOI":"10.1016\/j.rmed.2021.106689","article-title":"Kinetic changes in serum KL-6 levels predict disease progression in patients with systemic sclerosis-associated interstitial lung disease","volume":"191","author":"Watanabe","year":"2022","journal-title":"Respir Med"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae083\/56762171\/keae083.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/2\/658\/56762171\/keae083.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/2\/658\/56762171\/keae083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T03:35:45Z","timestamp":1743392145000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/2\/658\/7601350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,6]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,6]]},"published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae083","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,2,6]]}}}